[VRDN] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
10-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -60.09%
YoY- -166.88%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 72 72 72 98 105 1,195 256 -56.97%
PBT -66,860 -47,660 -55,063 -68,151 -45,785 -28,905 -29,491 72.32%
Tax 5,534 -135 4,378 -105 -3,281 -880 227 735.88%
NP -66,860 -47,660 -55,063 -68,046 -42,504 -28,025 -29,491 72.32%
Tax Rate - - - - - - - -
Total Cost 66,932 47,732 55,135 68,144 42,609 29,220 29,747 71.45%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -92,861.11 -66,194.44 -76,476.39 -69,434.69 -40,480.00 -2,345.19 -11,519.92 300.50%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -1.35 -1.09 -1.27 -1.61 -1.05 -0.83 -1.06 17.44%
EPS Diluted -1.35 -1.09 -1.27 -1.61 -1.05 -0.83 -1.06 17.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.